Search research articles
Contact Us
Filters
Showing results (371-380 of 596) with videos related to
Page
of 60
Sort By:
JAMA Cardiology
|
December 13, 2018
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial
Christoph B Olivier, Hillary Mulder, William R Hiatt, et al.
Vascular Medicine (London, England)
|
April 7, 2022
Impact of risk factor control on peripheral artery disease outcomes and health disparities
F Will Pohlman, Cassie B Ford, E Hope Weissler, et al.
Journal of the American Heart Association
|
February 8, 2021
Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel-Coated Devices: Insights From the Veterans Health Administration
Jorge Antonio Gutierrez, Sunil V Rao, William Schuyler Jones, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 10, 2021
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial
E Hope Weissler, Robert M Clare, Yuliya Lokhnygina, et al.
American Heart Journal
|
November 10, 2012
The study of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): design and rationale
Chiara Melloni, Dennis L Sprecher, Lea Sarov-Blat, et al.
Journal of the American Heart Association
|
September 8, 2020
Practice Pattern, Diagnostic Yield, and Long-Term Prognostic Impact of Coronary Computed Tomographic Angiography
Min Soo Cho, Jae-Hyung Roh, Hanbit Park, et al.
Circulation
|
July 1, 2016
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF
Christopher B Fordyce, Anne S Hellkamp, Yuliya Lokhnygina, et al.
American Heart Journal
|
August 10, 2016
Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial
Sreekanth Vemulapalli, Anne S Hellkamp, W Schuyler Jones, et al.
The American Journal of Medicine
|
August 21, 2016
Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial)
Rohan Shah, Robert M Clare, Karen Chiswell, et al.
JACC. Cardiovascular Imaging
|
February 5, 2010
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial
Manesh R Patel, Stephen G Worthley, Amanda Stebbins, et al.
Page
of 60
Search research articles
Search
Showing results (371-380 of 596) with videos related to
Sort By:
Page
of 60
JAMA Cardiology
|
December 13, 2018
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial
Christoph B Olivier, Hillary Mulder, William R Hiatt, et al.
Vascular Medicine (London, England)
|
April 7, 2022
Impact of risk factor control on peripheral artery disease outcomes and health disparities
F Will Pohlman, Cassie B Ford, E Hope Weissler, et al.
Journal of the American Heart Association
|
February 8, 2021
Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel-Coated Devices: Insights From the Veterans Health Administration
Jorge Antonio Gutierrez, Sunil V Rao, William Schuyler Jones, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 10, 2021
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial
E Hope Weissler, Robert M Clare, Yuliya Lokhnygina, et al.
American Heart Journal
|
November 10, 2012
The study of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): design and rationale
Chiara Melloni, Dennis L Sprecher, Lea Sarov-Blat, et al.
Journal of the American Heart Association
|
September 8, 2020
Practice Pattern, Diagnostic Yield, and Long-Term Prognostic Impact of Coronary Computed Tomographic Angiography
Min Soo Cho, Jae-Hyung Roh, Hanbit Park, et al.
Circulation
|
July 1, 2016
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF
Christopher B Fordyce, Anne S Hellkamp, Yuliya Lokhnygina, et al.
American Heart Journal
|
August 10, 2016
Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial
Sreekanth Vemulapalli, Anne S Hellkamp, W Schuyler Jones, et al.
The American Journal of Medicine
|
August 21, 2016
Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial)
Rohan Shah, Robert M Clare, Karen Chiswell, et al.
JACC. Cardiovascular Imaging
|
February 5, 2010
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial
Manesh R Patel, Stephen G Worthley, Amanda Stebbins, et al.
Page
of 60